Company Description
RNVAD (OTC: RNVAD) is a publicly traded diagnostics & research company in the Healthcare sector. The company has a market capitalization of $20.8K.
RNVAD stock has declined 92.8% over the past year.
This page provides a comprehensive overview of RNVAD stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
RNVAD (RNVAD) stock. Over the past 12 months, the stock has lost 92.8%. At a market capitalization of $20.8K, RNVAD is classified as a micro-cap stock with approximately 2.9M shares outstanding.
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
RNVAD Company Profile & Sector Positioning
RNVAD (RNVAD) operates in the Diagnostics & Research industry within the broader Healthcare sector.
Investors comparing RNVAD often look at related companies in the same sector, including Inotiv Inc (NOTV), Precipio Inc (PRPO), Prophase Labs Inc (PRPH), Ispecimen Inc. (ISPC), and Advanced Biomed Inc. (ADVB). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate RNVAD's relative position within its industry.